2019 Vol.37, N°2 - Table of contents
March-April 2019
One year in review
CER12208
2019,37,2
Pg. 0167-0178
Free to view
One year in review 2018: psoriatic arthritis
E. Calabresi, S. Monti, G. Governato, L. Carli
E. Calabresi, S. Monti, G. Governato, L. Carli
Full Papers
CER11160
2019,37,2
Pg. 0179-0185
Free to view
Prevention of the progressive biochemical cartilage destruction under methotrexate therapy in early rheumatoid arthritis
P. Sewerin, A. Müller-Lutz, D.B. Abrar, S. Odendahl, M. Eichner, M. Schneider, B. Ostendorf, C. Schleich
P. Sewerin, A. Müller-Lutz, D.B. Abrar, S. Odendahl, M. Eichner, M. Schneider, B. Ostendorf, C. Schleich
CER11183
2019,37,2
Pg. 0186-0192
Free to view
Reduced quality of life impacts knowledge and type of informed consent in rheumatoid arthritis patients.
V. Pascual-Ramos, I. Contreras-Yáñez, D. Ruiz, M. De la luz casas-Martínez
V. Pascual-Ramos, I. Contreras-Yáñez, D. Ruiz, M. De la luz casas-Martínez
CER11229
2019,37,2
Pg. 0193-0198
Free to view
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis
S. Scriffignano, F.M. Perrotta, A. De Socio, A. Altobelli, P. Sessa, R. Scrivo, G. Valesini, E. Lubrano
S. Scriffignano, F.M. Perrotta, A. De Socio, A. Altobelli, P. Sessa, R. Scrivo, G. Valesini, E. Lubrano
CER11207
2019,37,2
Pg. 0199-0207
Free to view
Clinical and quality of life improvements with golimumab or infliximab in a real-life ankylosing spondylitis population: the QUO-VADIS study
F. Van Den Bosch, R.-M. Flipo, J. Braun, N. Vastesaeger, S. Kachroo, M. Govoni
F. Van Den Bosch, R.-M. Flipo, J. Braun, N. Vastesaeger, S. Kachroo, M. Govoni
CER11199
2019,37,2
Pg. 0208-0214
Free to view
Immunological signatures in saliva of systemic lupus erythematosus patients: influence of periodontal condition
S.M. Mendonça, J.D. Corrêa, A.F. Souza, D.V. Travassos, D.C. Calderaro, N.P. Rocha, É.L. Vieira, A.L. Teixeira, G.A. Ferreira, T.A. Silva
S.M. Mendonça, J.D. Corrêa, A.F. Souza, D.V. Travassos, D.C. Calderaro, N.P. Rocha, É.L. Vieira, A.L. Teixeira, G.A. Ferreira, T.A. Silva
CER11118
2019,37,2
Pg. 0215-0221
Free to view
Clinical and genetic characteristics of ankylosing spondylitis patients with peripheral arthritis at disease onset
J. Polo Y La Borda, M. Szczypiorska, N. Bartolomé, J. Campos, B.J. Flores-Robles, J. Sanz, C. Fernández-Espartero, T. Clavaguera, R.F. Andrus, M. Artieda, D. Tejedor, A. Martínez, J. Mulero, C.M. Isasi, J.L. Andréu, A. Sánchez
J. Polo Y La Borda, M. Szczypiorska, N. Bartolomé, J. Campos, B.J. Flores-Robles, J. Sanz, C. Fernández-Espartero, T. Clavaguera, R.F. Andrus, M. Artieda, D. Tejedor, A. Martínez, J. Mulero, C.M. Isasi, J.L. Andréu, A. Sánchez
CER11146
2019,37,2
Pg. 0222-0226
Free to view
Association of a polymorphism of the Fcγ-receptor 2A (FCGR2A) gene with chronic periaortitis
F. Alberici, F. Bonatti, F. Maritati, M.L. Urban, G. Moroni, G. Emmi, A. Adorni, M. Reina, A. Vaglio, D. Martorana
F. Alberici, F. Bonatti, F. Maritati, M.L. Urban, G. Moroni, G. Emmi, A. Adorni, M. Reina, A. Vaglio, D. Martorana
CER11202
2019,37,2
Pg. 0227-0234
Free to view
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
L. Bi, Y. Li, L. He, H. Xu, Z. Jiang, Y. Wang, X. Li, W. Wei, J. Gu, G. Wang, Z. Zhang, B. Zhou, Y. Liu, Z. Wu, H. Liu, D. He, Z. Lv, Z. Li, X. Zuo, L. Dong, H. Wu, H. Zhang, H. Chen, C. Bao, Z. Zhang, M. Zhang, H. Song, Y. Zheng, L. Jiang, X. Liu, M. Boehnlein, J. Dunkel, J. Shao, K. Harris, Z. Li
L. Bi, Y. Li, L. He, H. Xu, Z. Jiang, Y. Wang, X. Li, W. Wei, J. Gu, G. Wang, Z. Zhang, B. Zhou, Y. Liu, Z. Wu, H. Liu, D. He, Z. Lv, Z. Li, X. Zuo, L. Dong, H. Wu, H. Zhang, H. Chen, C. Bao, Z. Zhang, M. Zhang, H. Song, Y. Zheng, L. Jiang, X. Liu, M. Boehnlein, J. Dunkel, J. Shao, K. Harris, Z. Li
CER11310
2019,37,2
Pg. 0235-0241
Free to view
Feasibility, safety and efficacy of exercise training in immune-mediated necrotising myopathies: a quasi-experimental prospective study
J.M. De Souza, D.S. De Oliveira, L.A. Perin, R.G. Misse, A.M. Dos Santos, B. Gualano, A.L. De Sá Pinto, H. Roschel, F.R. Lima, S.K. Shinjo
J.M. De Souza, D.S. De Oliveira, L.A. Perin, R.G. Misse, A.M. Dos Santos, B. Gualano, A.L. De Sá Pinto, H. Roschel, F.R. Lima, S.K. Shinjo
CER11156
2019,37,2
Pg. 0242-0253
Free to view
Associations between interleukin-10 gene polymorphisms and systemic lupus erythematosus risk: a meta-analysis with trial sequential analysis
Y. Yuan, X. Wang, L. Ren, Y. Kong, J. Bai, Y. Yan
Y. Yuan, X. Wang, L. Ren, Y. Kong, J. Bai, Y. Yan
CER11134
2019,37,2
Pg. 0254-0259
Free to view
Clinical features and risk of recurrence of acute calcium pyrophosphate crystal arthritis
J.S. Lee, S. Hong, O.C. Kwon, B. Ghang, Y.-G. Kim, C.-K. Lee, B. Yoo
J.S. Lee, S. Hong, O.C. Kwon, B. Ghang, Y.-G. Kim, C.-K. Lee, B. Yoo
CER11119
2019,37,2
Pg. 0260-0269
Free to view
Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE 2 stud
A. Deodhar, P.G. Conaghan, T.K. Kvien, V. Strand, B. Sherif, B. Porter, S.M. Jugl, K.K. Gandhi
on behalf of the MEASURE 2 study group
A. Deodhar, P.G. Conaghan, T.K. Kvien, V. Strand, B. Sherif, B. Porter, S.M. Jugl, K.K. Gandhi
on behalf of the MEASURE 2 study group
CER11150
2019,37,2
Pg. 0270-0278
Free to view
Reciprocal interaction between macrophage migration inhibitory factor and interleukin-8 in gout
K.-W. Kim, B.-M. Kim, K.-A. Lee, H.-S. Kim, S.-H. Lee, H.-R. Kim
K.-W. Kim, B.-M. Kim, K.-A. Lee, H.-S. Kim, S.-H. Lee, H.-R. Kim
CER11295
2019,37,2
Pg. 0279-0285
Free to view
Antineutrophil cytoplasmic antibody and/or antiglomerular basement membrane antibody associated crescentic glomerulonephritis in combination with IgG4-related tubulointerstitial nephritis
G.Q. Wang, Y.P. Chen, H. Cheng, X.Y. Xu, L.J. Sun, H.R. Dong
G.Q. Wang, Y.P. Chen, H. Cheng, X.Y. Xu, L.J. Sun, H.R. Dong
CER11255
2019,37,2
Pg. 0286-0292
Free to view
Association between non-dipper hypertension and vitamin D deficiency in women with systemic lupus erythematosus
J.M. Sabio, J.A. Vargas-Hitos, J. Martínez-Bordonado, J.D. Mediavilla-García
J.M. Sabio, J.A. Vargas-Hitos, J. Martínez-Bordonado, J.D. Mediavilla-García
CER11189
2019,37,2
Pg. 0293-0300
Free to view
Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition
A. Fioravanti, S. Tenti, M.R. Bacarelli, A. Damiani, F. Li Gobbi, F. Bandinelli, S. Cheleschi, M. Galeazzi, M. Benucci
A. Fioravanti, S. Tenti, M.R. Bacarelli, A. Damiani, F. Li Gobbi, F. Bandinelli, S. Cheleschi, M. Galeazzi, M. Benucci
Brief Papers
CER11213
2019,37,2
Pg. 0301-0305
Free to view
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis
C. Fabiani, A. Vitale, D. Rigante, G. Emmi, G. Lopalco, J. Sota, L. Vannozzi, S. Guerriero, A. Bitossi, I. Orlando, R. Franceschini, B. Frediani, M. Galeazzi, F. Iannone, G.M. Tosi, L. Cantarini
C. Fabiani, A. Vitale, D. Rigante, G. Emmi, G. Lopalco, J. Sota, L. Vannozzi, S. Guerriero, A. Bitossi, I. Orlando, R. Franceschini, B. Frediani, M. Galeazzi, F. Iannone, G.M. Tosi, L. Cantarini
CER11387
2019,37,2
Pg. 0306-0309
Free to view
Fibroblast-like synoviocytes from fluid and synovial membrane from primary osteoarthritis demonstrate similar production of interleukin 6, and metalloproteinases 1 and 3
C.R. Machado, G.G. Resende, R.B. Macedo, V.C. Do Nascimento, A.S. Branco, A.M. Kakehasi, M.V. Andrade
C.R. Machado, G.G. Resende, R.B. Macedo, V.C. Do Nascimento, A.S. Branco, A.M. Kakehasi, M.V. Andrade
Review
CER11129
2019,37,2
Pg. 0310-0317
Free to view
Clinical implications of peripheral new bone formation in psoriatic arthritis: a literature-based review
A. Marchesoni, R. Caporali, E. Lubrano
A. Marchesoni, R. Caporali, E. Lubrano
CER11253
2019,37,2
Pg. 0318-0323
Free to view
Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials
Z. Geng, Y. Yu, S. Hu, L. Dong, C. Ye
Z. Geng, Y. Yu, S. Hu, L. Dong, C. Ye
CER11414
2019,37,2
Pg. 0324-0332
Free to view
Epidemiological characteristics of psoriatic arthritis
M.P. Migkos, G.-P. Somarakis, T.E. Markatseli, P.V. Voulgari, A.A. Drosos
M.P. Migkos, G.-P. Somarakis, T.E. Markatseli, P.V. Voulgari, A.A. Drosos
Paediatric Rheumatology
CER11292
2019,37,2
Pg. 0333-0337
Free to view
Association between STAT4 polymorphisms and the risk of juvenile idiopathic arthritis in Han Chinese populations
X. Huang, Z. Wang, N. Jia, S. Shangguan, J. Lai, X. Cui, F. Wu, L. Wang
X. Huang, Z. Wang, N. Jia, S. Shangguan, J. Lai, X. Cui, F. Wu, L. Wang
Letter
CER11371
2019,37,2
Pg. 0338-0339
Free to view
S100A11 (calgizzarin) is released by circulating mononuclear cells and its elevated plasma levels distinguish systemic lupus erythematosus patients from healthy individuals
L.A. Cerezo, B. Šumová, H. Hulejová, H. Štorkánová, L. Szczuková, M. Tomčík, R. Bečvář, K. Pavelka, J. Vencovský, J. Závada, L. Šenolt
L.A. Cerezo, B. Šumová, H. Hulejová, H. Štorkánová, L. Szczuková, M. Tomčík, R. Bečvář, K. Pavelka, J. Vencovský, J. Závada, L. Šenolt
CER11645
2019,37,2
Pg. 0340-0341
Free to view
Interstitial lung pathology: should we test for autoantibodies to cellular antigens?
J. Serelis, A. Athanasakos, F.N. Skopouli, H.M. Moutsopoulos
J. Serelis, A. Athanasakos, F.N. Skopouli, H.M. Moutsopoulos
CER11633
2019,37,2
Pg. 0342-0343
Free to view
Real world use of secukinumab for treatment of axial spondyloarthritis and psoriatic arthritis: nationwide results from the ATTRA registry
H.F. Mann, J. Závada, L. Šenolt, K. Bubová, L. Nekvindová, Z. Křístková, P. Horák, J. Vencovský, K. Pavelka
and the ATTRA Registry
H.F. Mann, J. Závada, L. Šenolt, K. Bubová, L. Nekvindová, Z. Křístková, P. Horák, J. Vencovský, K. Pavelka
and the ATTRA Registry
CER11613
2019,37,2
Pg. 0344-0345
Free to view
Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis
E. Toussirot, C. Bernard, M. Bossert
E. Toussirot, C. Bernard, M. Bossert
Erratum Corrige
CER12248
2019,37,2
Pg. 0345
Free to view
Erratum corrige: “Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients”. M.F. Ugarte-Gil et al.
M.F. Ugarte-Gil, C. Sánchez-Zúñiga, R.V. Gamboa-Cardenas, M. Aliaga-Zamudio, F. Zevallos, A. Mosqueira-Riveros, M. Medina-Chinchón, G. Tineo-Pozo, C. Elera-Fitzcarrald, V. Pimentel-Quiroz, O. Sarmiento-Velasquez, C. Reátegui-Sokolova, J.M. Cucho-Venegas, J. Alfaro-Lozano, Z. Rodriguez-Bellido, C.A. Pastor-Asurza, G.S. Alarcón, R. Perich-Campos
M.F. Ugarte-Gil, C. Sánchez-Zúñiga, R.V. Gamboa-Cardenas, M. Aliaga-Zamudio, F. Zevallos, A. Mosqueira-Riveros, M. Medina-Chinchón, G. Tineo-Pozo, C. Elera-Fitzcarrald, V. Pimentel-Quiroz, O. Sarmiento-Velasquez, C. Reátegui-Sokolova, J.M. Cucho-Venegas, J. Alfaro-Lozano, Z. Rodriguez-Bellido, C.A. Pastor-Asurza, G.S. Alarcón, R. Perich-Campos